HHC. The officers of the Company in office immediately prior to the Effective Time shall be the officers of HHC upon the Effective Time and will continue to hold office from the Effective Time until the earlier of their resignation or removal or until their successors are duly elected or appointed and qualified in the manner provided in the HHC A&R Charter and HHC A&R Bylaws, or as otherwise provided by law.
HHC. CDS and DISTRIBUTOR promptly shall report to each other any change in applicable legislation or regulations or to the terms of a marketing authorization or approval of which they become aware that might alter their obligations under this procedure.
HHC. HHC is a state-owned enterprise principally engaged in investment holding of various companies listed or not listed on the stock exchanges of the mainland China and Hong Kong. Shandong Xinhua Pharmaceutical Branch Shandong Xinhua Pharmaceutical Branch Company is a branch company of HHC. It is mainly engaged in the investment, management, operations and consulting of chemical, pharmaceutical and environmental protection industries through its own funds. In case of any inconsistencies, the Chinese text of this announcement shall prevail over the English text. By Order of the Board Shandong Xinhua Pharmaceutical Company Limited Zhang Daiming Chairman 22 October 2020, Zibo, PRC As at the date of this announcement, the Board comprises: Executive Directors: Xx. Xxxxx Xxxxxxx (Chairman) Mr. Xx Xxxxxx Non-executive Directors: Xx. Xxx Xxxxxx Xx. Xx Xxx *for identification purpose only Independent Non-executive Directors: Xx. Xx Xxxxxxx
HHC. Housing & Healthcare Funding, LLC, a Delaware limited liability company.
HHC. CDS will be responsible for reviewing published/unpublished articles obtained as per Standard Operating Procedures. All adverse events identified in the literature will be processed as described in the above sections of this document. Literature articles will be supplied to DISTRIBUTOR upon request.
HHC. Except as set forth in Schedule 6.8 hereto, since March 31, 1997, in connection with the Business, HHC has not:
HHC. Except as listed and described on Schedule 1.63 and Schedule 2.1.3, HHC is not with respect to the Business a party to any written or oral:
HHC. Except as described in Schedule 6.14 hereto, there is no claim, action, suit, proceeding, investigation or inquiry pending before any Governmental Authority or, to HHC's Knowledge, threatened against HHC with respect to the Business or any of the Purchased Assets owned or used by it in connection therewith, or relating to the transactions contemplated by this Agreement, nor to HHC's Knowledge is there any basis for any such
HHC. To the best of the Directors’ knowledge, information and belief and having made all reasonable enquiry, HHC, together with its ultimate beneficial owner, are not connected persons of the Company and are third parties independent of the Company and its connected persons. Subject matter: XCTG and HHC have agreed that they will act in accordance with the agreed Mechanism as described below with regard to the approval of the following corporate matters of XHICT by the board of directors of XHICT: (i) annual operation plan; and (ii) financial budget and final accounts proposals relating to earnings before depreciation and amortisation, interests and taxes on the income statement (but excluding proposals relating to fixed asset expenditure, borrowing and profit distribution)(collectively the “Special Matters”).
HHC. HHC is a state-owned enterprise principally engaged in investment holding of various companies listed or not listed on the stock exchanges of the mainland China and Hong Kong. Shandong Xinhua Pharmaceutical Branch Shandong Xinhua Pharmaceutical Branch Company is a branch company of HHC. It is mainly engaged in the investment, management, operations and consulting of chemical, pharmaceutical and environmental protection industries through its own funds. In case of any inconsistencies, the Chinese text of this announcement shall prevail over the English text. By Order of the Board Shandong Xinhua Pharmaceutical Company Limited Xxxxx Xxxxxxx Chairman 22 October 2020, Zibo, PRC As at the date of this announcement, the Board comprises: Executive Directors: Xx. Xxxxx Xxxxxxx (Chairman) Mr. Xx Xxxxxx Independent Non-executive Directors: Xx. Xx Xxxxxxx Mr. Xx Xxxxxxx Xx. Xx Xxx Xxx Non-executive Directors: Xx. Xxx Xxxxxx Xx. Xx Xxx *for identification purpose only
